Klaudia Zacher
Klaudia Zacher has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Katarzyna Znamirowska
University Teaching Hospital them. F. Chopin in Rzeszów, Rzeszów, Poland
13 shared publications - Anna Rakoczy
University Teaching Hospital them. F. Chopin in Rzeszów, Rzeszów, Poland
10 shared publications - Jowita Frydrych
University Teaching Hospital them. F. Chopin in Rzeszów, Rzeszów, Poland
10 shared publications - Karolina Ochyra
Medical Center in Łańcut, Łańcut, Poland
10 shared publications - Karolina Ryba
University Teaching Hospital them. F. Chopin in Rzeszów, Rzeszów, Poland
10 shared publications - Kornelia Pudło
Independent Public Health Care Complex No. 1 in Rzeszów, Rzeszów, Poland
10 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
WHEN SKIN TURNS AGAINST THE BODY: A CLOSER LOOK AT SJS AND TEN
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis are very rare, severe, life-threatening dermatological conditions characterized by severe skin and mucosal changes. The most common triggers are drugs, including β-lactam antibiotics, allopurinol, nonsteroidal anti-inflammatory drugs, nevirapine, and febuxostat. This article reviews the literature from 2000-2025 on the clinical manifestations that characterize SJS/TEN, pathogenesis, diagnosis necessary for proper treatment, prognostic scales such as SCORTEN, ABCD-10 and CRISTEN useful for predicting patient mortality, and treatment. Due to the rarity and high mortality rate of people with SJS/TEN, there is still a lack of high-quality studies on the pathogenesis of the disease and evaluating the efficacy of immunomodulatory drugs in inhibiting epidermal necrolysis and reducing mortality.
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessWHEN SKIN TURNS AGAINST THE BODY: A CLOSER LOOK AT SJS AND TEN
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis are very rare, severe, life-threatening dermatological conditions characterized by severe skin and mucosal changes. The most common triggers are drugs, including β-lactam antibiotics, allopurinol, nonsteroidal anti-inflammatory drugs, nevirapine, and febuxostat. This article reviews the literature from 2000-2025 on the clinical manifestations that characterize SJS/TEN, pathogenesis, diagnosis necessary for proper treatment, prognostic scales such as SCORTEN, ABCD-10 and CRISTEN useful for predicting patient mortality, and treatment. Due to the rarity and high mortality rate of people with SJS/TEN, there is still a lack of high-quality studies on the pathogenesis of the disease and evaluating the efficacy of immunomodulatory drugs in inhibiting epidermal necrolysis and reducing mortality.
- Open Access
- 27 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Public Knowledge about Screening Tests in South-East Poland
Background: Neoplastic diseases constitute a major public health challenge globally and in Poland. Despite the implementation of population-based screening programs for breast, cervical, and colorectal cancer, participation rates in Poland remain unsatisfactory. Early detection is the most effective tool for reducing cancer mortality, yet it relies heavily on public awareness and health literacy. Aim: The aim of this study was to assess the level of knowledge and attitudes of adult residents of the Podkarpackie and Małopolskie voivodeships (south-east Poland) regarding screening tests, and to analyze the influence of sociodemographic factors on health behaviors. Material and methods: A cross-sectional survey was conducted among a diverse group of 288 adults (192 women and 95 men). The research tool was an original questionnaire containing 30 items regarding knowledge of screening types (mammography, cytology, colonoscopy), screening guidelines, and risk factors. Statistical analysis was performed using the Chi-square test (p<0.05). Results: While general awareness of screening is high (99.7% of respondents recognized the terms), specific knowledge regarding frequency and age criteria is lacking. Education level proved to be the strongest predictor of adequate knowledge (p<0.001). A significant misconception regarding smoking was observed in the 50–65 age group, where many respondents believed smoking does not increase lung cancer risk. The main perceived barriers were low availability and lack of promotion. Conclusions: There is a critical need for targeted educational campaigns, particularly addressing men and individuals with lower education levels. The misconceptions prevalent in the 50–65 age group require immediate rectification to improve the effectiveness of lung cancer prevention.
- 27 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Open AccessPublic Knowledge about Screening Tests in South-East Poland
Background: Neoplastic diseases constitute a major public health challenge globally and in Poland. Despite the implementation of population-based screening programs for breast, cervical, and colorectal cancer, participation rates in Poland remain unsatisfactory. Early detection is the most effective tool for reducing cancer mortality, yet it relies heavily on public awareness and health literacy. Aim: The aim of this study was to assess the level of knowledge and attitudes of adult residents of the Podkarpackie and Małopolskie voivodeships (south-east Poland) regarding screening tests, and to analyze the influence of sociodemographic factors on health behaviors. Material and methods: A cross-sectional survey was conducted among a diverse group of 288 adults (192 women and 95 men). The research tool was an original questionnaire containing 30 items regarding knowledge of screening types (mammography, cytology, colonoscopy), screening guidelines, and risk factors. Statistical analysis was performed using the Chi-square test (p<0.05). Results: While general awareness of screening is high (99.7% of respondents recognized the terms), specific knowledge regarding frequency and age criteria is lacking. Education level proved to be the strongest predictor of adequate knowledge (p<0.001). A significant misconception regarding smoking was observed in the 50–65 age group, where many respondents believed smoking does not increase lung cancer risk. The main perceived barriers were low availability and lack of promotion. Conclusions: There is a critical need for targeted educational campaigns, particularly addressing men and individuals with lower education levels. The misconceptions prevalent in the 50–65 age group require immediate rectification to improve the effectiveness of lung cancer prevention.
- Open Access
- 26 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
MULTIPLE SCLEROSIS EXPLAINED: FROM PATHOPHYSIOLOGY TO DIAGNOSIS AND MANAGEMENT
Multiple sclerosis (MS) is a chronic, autoimmune disease of the central nervous system that leads to the destruction of the myelin sheaths in the brain and spinal cord, resulting in progressive disability. It most commonly affects young adults, with a higher prevalence in women. The exact causes of MS remain unclear. It is believed that genetic and environmental factors, such as viral infections and vitamin D deficiency, play a significant role in the disease's development. MS typically follows a relapsing-remitting course, with periods of exacerbation and clinical improvement. The symptoms of MS are highly variable and depend on the location of demyelinating lesions. The onset of the disease may be asymptomatic. Early symptoms often include vision disturbances, paresthesia, and aphasia. In advanced stages, patients may experience spasticity, tremors, bowel and bladder dysfunction, sexual dysfunction, dizziness, cognitive impairments, and pain. Treatment of MS requires an individualized approach that combines pharmacotherapy with rehabilitation. Despite advances in therapy, the disease can still shorten life expectancy by several years and significantly impact the quality of daily functioning. Aim of the Study: The aim of this article is to present the current state of knowledge on multiple sclerosis, including a discussion of its causes, symptoms, diagnostic methods, and available therapeutic options. Materials and Methods: A review of the available literature of Google Scholar, PubMed. Results: Multiple sclerosis (MS) is a chronic, autoimmune inflammatory disease that leads to damage to the myelin sheaths in the central nervous system, resulting in a variety of neurological symptoms. The pathogenesis of the disease involves genetic, environmental, and immunological factors. Patients with MS experience a decline in quality of life, particularly in terms of social and professional functioning, due to progressive disability and psychological symptoms. Disease-modifying treatments (DMTs), and biologic drugs, significantly reduce the frequency of relapses and delay disease progression.
- 26 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessMULTIPLE SCLEROSIS EXPLAINED: FROM PATHOPHYSIOLOGY TO DIAGNOSIS AND MANAGEMENT
Multiple sclerosis (MS) is a chronic, autoimmune disease of the central nervous system that leads to the destruction of the myelin sheaths in the brain and spinal cord, resulting in progressive disability. It most commonly affects young adults, with a higher prevalence in women. The exact causes of MS remain unclear. It is believed that genetic and environmental factors, such as viral infections and vitamin D deficiency, play a significant role in the disease's development. MS typically follows a relapsing-remitting course, with periods of exacerbation and clinical improvement. The symptoms of MS are highly variable and depend on the location of demyelinating lesions. The onset of the disease may be asymptomatic. Early symptoms often include vision disturbances, paresthesia, and aphasia. In advanced stages, patients may experience spasticity, tremors, bowel and bladder dysfunction, sexual dysfunction, dizziness, cognitive impairments, and pain. Treatment of MS requires an individualized approach that combines pharmacotherapy with rehabilitation. Despite advances in therapy, the disease can still shorten life expectancy by several years and significantly impact the quality of daily functioning. Aim of the Study: The aim of this article is to present the current state of knowledge on multiple sclerosis, including a discussion of its causes, symptoms, diagnostic methods, and available therapeutic options. Materials and Methods: A review of the available literature of Google Scholar, PubMed. Results: Multiple sclerosis (MS) is a chronic, autoimmune inflammatory disease that leads to damage to the myelin sheaths in the central nervous system, resulting in a variety of neurological symptoms. The pathogenesis of the disease involves genetic, environmental, and immunological factors. Patients with MS experience a decline in quality of life, particularly in terms of social and professional functioning, due to progressive disability and psychological symptoms. Disease-modifying treatments (DMTs), and biologic drugs, significantly reduce the frequency of relapses and delay disease progression.
- Open Access
- 25 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
NON-ANTIBIOTIC SUBSTANCES IN THE TREATMENT AND PREVENTION OF RECURRENT URINARY TRACT INFECTIONS
Urinary tract infections (UTI) create a serious health problem worldwide, affecting people of all ages. It represents one of the most common reasons for the use of antibiotics in outpatient care, leading to a reduction in their effectiveness through ever-increasing bacterial resistance to them. Thus, there is an urgent need to develop new and effective therapies. The purpose of this paper is to present alternative therapies that can help prevent and treat recurrent UTIs, such as cranberry preparations, D-mannose, robotics and topical estrogen. After analyzing the available studies, it was shown that each of these substances can have a beneficial effect on reducing recurrent UTIs, although their effectiveness varies. Substances with high therapeutic potential appear to be D-mannose and probiotics. Their action is based on supporting the natural human microflora and blocking bacterial adhesion to the epithelium of the urinary tract. A preventive strategy in the context of UTI in postmenopausal women seems to be vaginal estrogen. However, further robustly designed clinical trials need to be conducted to truly confirm that these therapies are effective and safe in terms of long-term efficacy.
- 25 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessNON-ANTIBIOTIC SUBSTANCES IN THE TREATMENT AND PREVENTION OF RECURRENT URINARY TRACT INFECTIONS
Urinary tract infections (UTI) create a serious health problem worldwide, affecting people of all ages. It represents one of the most common reasons for the use of antibiotics in outpatient care, leading to a reduction in their effectiveness through ever-increasing bacterial resistance to them. Thus, there is an urgent need to develop new and effective therapies. The purpose of this paper is to present alternative therapies that can help prevent and treat recurrent UTIs, such as cranberry preparations, D-mannose, robotics and topical estrogen. After analyzing the available studies, it was shown that each of these substances can have a beneficial effect on reducing recurrent UTIs, although their effectiveness varies. Substances with high therapeutic potential appear to be D-mannose and probiotics. Their action is based on supporting the natural human microflora and blocking bacterial adhesion to the epithelium of the urinary tract. A preventive strategy in the context of UTI in postmenopausal women seems to be vaginal estrogen. However, further robustly designed clinical trials need to be conducted to truly confirm that these therapies are effective and safe in terms of long-term efficacy.
- Open Access
- 19 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
PHARMACOLOGICAL MANAGEMENT OF DEPRESSION AND HALLUCINATIONS IN PARKINSON’S DISEASE: A COMPREHENSIVE REVIEW
Purpose: The aim of this study is to present available treatment options for depression and hallucinations in Parkinson’s disease (PD). The review discusses the application of serotonin-norepinephrine reuptake inhibitors (SNRIs, e.g., duloxetine), selective serotonin reuptake inhibitors (SSRIs, e.g., paroxetine, escitalopram), pimavanserin, pramipexole, and repetitive transcranial magnetic stimulation (rTMS) in the treatment of depressive symptoms in PD. Moreover, the therapeutic use of atypical antipsychotics such as clozapine, quetiapine, and pimavanserin in managing hallucinations in PD is addressed. Materials and Methods: This review is based on literature identified via Google Scholar. Results and Conclusions: SSRIs are among the most commonly prescribed agents in the treatment of depression associated with Parkinson’s disease, although robust evidence supporting their efficacy in large cohorts remains limited. Other therapeutic options include SNRIs and tricyclic antidepressants. In cases of Parkinson’s disease-related hallucinations, the initial approach involves reducing dopaminergic medication doses to rule out drug-induced psychosis. If symptoms persist, second-generation atypical antipsychotics may be introduced. Clozapine and quetiapine are preferred over agents such as olanzapine and risperidone due to a more favorable motor side effect profile. Pimavanserin stands out as a promising agent due to its minimal adverse effects and high safety profile in this patient population.
- 19 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessPHARMACOLOGICAL MANAGEMENT OF DEPRESSION AND HALLUCINATIONS IN PARKINSON’S DISEASE: A COMPREHENSIVE REVIEW
Purpose: The aim of this study is to present available treatment options for depression and hallucinations in Parkinson’s disease (PD). The review discusses the application of serotonin-norepinephrine reuptake inhibitors (SNRIs, e.g., duloxetine), selective serotonin reuptake inhibitors (SSRIs, e.g., paroxetine, escitalopram), pimavanserin, pramipexole, and repetitive transcranial magnetic stimulation (rTMS) in the treatment of depressive symptoms in PD. Moreover, the therapeutic use of atypical antipsychotics such as clozapine, quetiapine, and pimavanserin in managing hallucinations in PD is addressed. Materials and Methods: This review is based on literature identified via Google Scholar. Results and Conclusions: SSRIs are among the most commonly prescribed agents in the treatment of depression associated with Parkinson’s disease, although robust evidence supporting their efficacy in large cohorts remains limited. Other therapeutic options include SNRIs and tricyclic antidepressants. In cases of Parkinson’s disease-related hallucinations, the initial approach involves reducing dopaminergic medication doses to rule out drug-induced psychosis. If symptoms persist, second-generation atypical antipsychotics may be introduced. Clozapine and quetiapine are preferred over agents such as olanzapine and risperidone due to a more favorable motor side effect profile. Pimavanserin stands out as a promising agent due to its minimal adverse effects and high safety profile in this patient population.
- Open Access
- 18 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
CARDIOFACIOCUTANEOUS SYNDROME (CFCS) IN THE LIGHT OF CONTEMPORARY RESEARCH - A REVIEW OF THE LITERATURE
The term RASopathies was introduced to describe a group of genetic syndromes that share similar phenotypic features and a common molecular basis. RASopathies are among the most numerous groups of recognized congenital developmental disorders. These syndromes have variable clinical courses, and the phenotypic features observed in newborns may differ from those seen in later stages of life - childhood, adolescence, or adulthood - which significantly complicates accurate clinical diagnosis. The underlying cause of these disorders involves mutations in genes encoding proteins associated with the Ras/MAPK (mitogen-activated protein kinase) signaling pathway. Cardiofaciocutaneous syndrome (CFCS) is a representative RASopathy, clinically defined by distinctive craniofacial dysmorphism, congenital heart defects, dermatological anomalies, postnatal growth retardation, and varying degrees of intellectual disability. Recent advances in molecular genetics have facilitated, at least to some extent, the differential diagnosis of CFCS, thereby improving diagnostic accuracy. Lifelong, multidisciplinary medical management is essential for both pediatric and adult patients, necessitating coordinated care involving specialists from various medical fields. This article focuses on the molecular pathogensis, clinical features, prenatal findings and recommended evaluations following initial diagnosis. Materials: We conducted a review and analysis of the literature available in the PubMed database, using keywords.
- 18 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessCARDIOFACIOCUTANEOUS SYNDROME (CFCS) IN THE LIGHT OF CONTEMPORARY RESEARCH - A REVIEW OF THE LITERATURE
The term RASopathies was introduced to describe a group of genetic syndromes that share similar phenotypic features and a common molecular basis. RASopathies are among the most numerous groups of recognized congenital developmental disorders. These syndromes have variable clinical courses, and the phenotypic features observed in newborns may differ from those seen in later stages of life - childhood, adolescence, or adulthood - which significantly complicates accurate clinical diagnosis. The underlying cause of these disorders involves mutations in genes encoding proteins associated with the Ras/MAPK (mitogen-activated protein kinase) signaling pathway. Cardiofaciocutaneous syndrome (CFCS) is a representative RASopathy, clinically defined by distinctive craniofacial dysmorphism, congenital heart defects, dermatological anomalies, postnatal growth retardation, and varying degrees of intellectual disability. Recent advances in molecular genetics have facilitated, at least to some extent, the differential diagnosis of CFCS, thereby improving diagnostic accuracy. Lifelong, multidisciplinary medical management is essential for both pediatric and adult patients, necessitating coordinated care involving specialists from various medical fields. This article focuses on the molecular pathogensis, clinical features, prenatal findings and recommended evaluations following initial diagnosis. Materials: We conducted a review and analysis of the literature available in the PubMed database, using keywords.
- Open Access
- 1 September 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (3) , 674-681
The knowledge of society regarding health-promoting behaviors in oncology
Introduction and aim. Enhancing awareness, early detection, and fostering health-seeking behavior is imperative to address the growing problem of cancer, advocating for basic health education from an early age to reduce morbidity and mortality. Material and methods. The survey was carried out in two forms: paper and online. The research tool was a questionnaire, consisting of 25 closed-ended questions. Results. While 95.5% denied the presence of personal cancer, 63% reported family history. Despite awareness of the impact (83% women; 81% men), 44% consume fast food monthly. Self-examination rates are low: only 37% perform it regularly; 45% of men lack knowledge of testicular examination. Conclusions. Health campaigns across all age groups are necessary to promote cancer prevention and early detection, with a focus on educating both men and women on self-examination due to inadequate knowledge levels.
- 1 September 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (3) , 674-681
Open AccessThe knowledge of society regarding health-promoting behaviors in oncology
Introduction and aim. Enhancing awareness, early detection, and fostering health-seeking behavior is imperative to address the growing problem of cancer, advocating for basic health education from an early age to reduce morbidity and mortality. Material and methods. The survey was carried out in two forms: paper and online. The research tool was a questionnaire, consisting of 25 closed-ended questions. Results. While 95.5% denied the presence of personal cancer, 63% reported family history. Despite awareness of the impact (83% women; 81% men), 44% consume fast food monthly. Self-examination rates are low: only 37% perform it regularly; 45% of men lack knowledge of testicular examination. Conclusions. Health campaigns across all age groups are necessary to promote cancer prevention and early detection, with a focus on educating both men and women on self-examination due to inadequate knowledge levels.
- Open Access
- 7 August 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 44, 62828
Management of opioid-induced constipation in palliative patients with disseminated cancer
Stool constipation is one of the most common afflictions affecting palliative patients with advanced cancer. The widespread use of opioids in the analgetic treatment of this group of patients exacerbates the already existing problem of constipation or is the underlying cause of its occurrence. Often, however, the etiology of the condition appears to be multifactorial. This article discusses the effects of opioids on the gastrointestinal tract as a cause of constipation, other possible causes of constipation in palliative patients, helpful definitions and how to diagnose constipation in this group of patients. Another important topic highlighted is the possibility of gastrointestinal obstruction and the possible management of its presence. Finally, the management of constipation is discussed, taking into account both non-pharmacological and pharmacological treatment with traditional laxatives and peripheral opioid receptor antagonists (naldemedine, naloxegol, methylnaltrexone). The article is based on an analysis of the available scientific literature and cited sources.
- 7 August 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 44, 62828
Open AccessManagement of opioid-induced constipation in palliative patients with disseminated cancer
Stool constipation is one of the most common afflictions affecting palliative patients with advanced cancer. The widespread use of opioids in the analgetic treatment of this group of patients exacerbates the already existing problem of constipation or is the underlying cause of its occurrence. Often, however, the etiology of the condition appears to be multifactorial. This article discusses the effects of opioids on the gastrointestinal tract as a cause of constipation, other possible causes of constipation in palliative patients, helpful definitions and how to diagnose constipation in this group of patients. Another important topic highlighted is the possibility of gastrointestinal obstruction and the possible management of its presence. Finally, the management of constipation is discussed, taking into account both non-pharmacological and pharmacological treatment with traditional laxatives and peripheral opioid receptor antagonists (naldemedine, naloxegol, methylnaltrexone). The article is based on an analysis of the available scientific literature and cited sources.
- Open Access
- 26 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 61225
Impact of physical activity on the development of dementia
Issues related to disease prevention are being increasingly addressed, particularly through the prevention of diseases by identification and verification of risk factors. One condition that is associated with an increasing incidence among the aging population is dementia, which places a burden on health care systems and the caregivers. The purpose of this studyis to explore the relationship between physical activity and the development of dementia based on the available literature. Understanding how exercise and sports can help prevent dementia may prove crucial in its prevention. Research indicates that physical activity has an impact on preventing and delaying the development of dementia by reducing cardiovascular risk factors and having a neuroprotective effect. However, the effectiveness of physical activity, the type of sport and environmental conditions plays a major role in this aspect. Notably, evidence suggests that contact sports and strenuous physical work can promote the development of dementia.
- 26 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 61225
Open AccessImpact of physical activity on the development of dementia
Issues related to disease prevention are being increasingly addressed, particularly through the prevention of diseases by identification and verification of risk factors. One condition that is associated with an increasing incidence among the aging population is dementia, which places a burden on health care systems and the caregivers. The purpose of this studyis to explore the relationship between physical activity and the development of dementia based on the available literature. Understanding how exercise and sports can help prevent dementia may prove crucial in its prevention. Research indicates that physical activity has an impact on preventing and delaying the development of dementia by reducing cardiovascular risk factors and having a neuroprotective effect. However, the effectiveness of physical activity, the type of sport and environmental conditions plays a major role in this aspect. Notably, evidence suggests that contact sports and strenuous physical work can promote the development of dementia.
- Open Access
- 20 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 60935
The Adenomyosis and infertility - underestimated challenge in reproductive medicine
Introduction: Adenomyosis is considered as a chronic gynecological condition increasingly observed among women of reproductive age. It remains underdiagnosed and frequently underestimated as a contributing factor in fertility disorders. Characterized by the presence of endometrial glands and stroma within the myometrium, adenomyosis causes progressive structural and functional uterine changes that may impair endometrial receptivity and disrupt implantation. Aim of the study: This review aims to summarize current knowledge on the effects of adenomyosis on fertility. It focuses on the pathophysiological mechanisms involved, diagnostic tools, classification systems.. It explores the pathophysiological mechanisms that contribute to impaired reproductive outcomes, as well as available diagnostic methods that enable an effective identification of the condition. Materials and methodology:The literature review includes articles from databases (PubMed), selected to their citation, using keywords “adenomyosis”, “infertility” Conclusion: Adenomyosis is increasingly recognized as a potential contributing factor to female infertility. Anatomical and functional alterations within the uterus may impair embryo implantation and early pregnancy development. Current evidence highlights the importance of including adenomyosis in the diagnostic work-up and management of infertile patients. A deeper understanding of its underlying mechanisms may lead to more effective and individualized treatment strategies.
- 20 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 60935
Open AccessThe Adenomyosis and infertility - underestimated challenge in reproductive medicine
Introduction: Adenomyosis is considered as a chronic gynecological condition increasingly observed among women of reproductive age. It remains underdiagnosed and frequently underestimated as a contributing factor in fertility disorders. Characterized by the presence of endometrial glands and stroma within the myometrium, adenomyosis causes progressive structural and functional uterine changes that may impair endometrial receptivity and disrupt implantation. Aim of the study: This review aims to summarize current knowledge on the effects of adenomyosis on fertility. It focuses on the pathophysiological mechanisms involved, diagnostic tools, classification systems.. It explores the pathophysiological mechanisms that contribute to impaired reproductive outcomes, as well as available diagnostic methods that enable an effective identification of the condition. Materials and methodology:The literature review includes articles from databases (PubMed), selected to their citation, using keywords “adenomyosis”, “infertility” Conclusion: Adenomyosis is increasingly recognized as a potential contributing factor to female infertility. Anatomical and functional alterations within the uterus may impair embryo implantation and early pregnancy development. Current evidence highlights the importance of including adenomyosis in the diagnostic work-up and management of infertile patients. A deeper understanding of its underlying mechanisms may lead to more effective and individualized treatment strategies.